|
TTC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63885999999724E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.96849999995119E-06 |
| Normal-vs-Stage2 |
2.334200E-01 |
| Normal-vs-Stage3 |
6.056700E-03 |
| Normal-vs-Stage4 |
7.977200E-04 |
| Stage1-vs-Stage2 |
1.009360E-01 |
| Stage1-vs-Stage3 |
3.587600E-01 |
| Stage1-vs-Stage4 |
3.215000E-01 |
| Stage2-vs-Stage3 |
4.165200E-01 |
| Stage2-vs-Stage4 |
7.042100E-02 |
| Stage3-vs-Stage4 |
1.612210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.09489999999823E-06 |
| Normal-vs-AfricanAmerican |
1.539180E-01 |
| Normal-vs-Asian |
1.879230E-01 |
| Caucasian-vs-AfricanAmerican |
4.214600E-01 |
| Caucasian-vs-Asian |
8.318200E-02 |
| AfricanAmerican-vs-Asian |
6.666400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.956090E-04 |
| Normal-vs-Female |
4.20119999999802E-05 |
| Male-vs-Female |
5.977800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.190270E-04 |
| Normal-vs-Age(41-60Yrs) |
2.800400E-04 |
| Normal-vs-Age(61-80Yrs) |
5.236400E-04 |
| Normal-vs-Age(81-100Yrs) |
8.752000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.373000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.380600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.239970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.195200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.716390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.503380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.006100E-02 |
| Classical-VS-Follicular |
5.938800E-01 |
| Classical-VS-Other |
3.794200E-01 |
| Classical-VS-Normal |
5.213400E-04 |
| Tall-VS-Follicular |
4.693000E-01 |
| Tall-VS-Other |
7.247600E-01 |
| Tall-VS-Normal |
5.80159999999941E-05 |
| Follicular-VS-Other |
5.989800E-01 |
| Follicular-VS-Normal |
5.075100E-03 |
| Other-VS-Normal |
9.316100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.137500E-03 |
| Normal-vs-N1 |
3.229100E-04 |
| N0-vs-N1 |
7.707800E-02 |
|
|
